Literature DB >> 9364689

Immunobiological activities of chemically defined lipid A from Helicobacter pylori LPS in comparison with Porphyromonas gingivalis lipid A and Escherichia coli-type synthetic lipid A (compound 506).

T Ogawa1, Y Suda, W Kashihara, T Hayashi, T Shimoyama, S Kusumoto, T Tamura.   

Abstract

Helicobacter pylori lipid A, characterised by a glucosamine beta (1-6) disaccharide 1-(2-aminoethyl)phosphate acylated by (R)-3-hydroxyoctadecanoic acid and (R)-3-(octadecanoyloxy)octadecanoic acid at the 2- and 2'-positions, respectively, exhibited no or very low endotoxic activities, i.e. lethal toxicity in galactosamine-loaded mice, pyrogenicity for rabbits and the activity of the Limulus test compared with Escherichia coli-type synthetic lipid A (compound 506), which possesses beta-(1-6)-linked glucosamine disaccharide 1,4'-bisphosphate, with two acyloxyacyl groups at the 2'- and 3'-positions and two 3-hydroxytetradecanoyl groups at the 2- and 3-positions. The endotoxic properties of H. pylori lipid A were also a little weaker than those of the low endotoxic lipid A of P. gingivalis, which has 1-phospho beta-(1-6)-linked glucosamine disaccharide with 3-hydroxy-15-methylhexadecanoyl and 3-hexadecanoyloxy-15-methylhexadecanoyl groups at the 2- and 2'-positions, respectively. Further, the mitogenic activity of H. pylori lipid A in murine splenic mononuclear cells was also less than those of P. gingivalis lipid A and compound 506. However, H. pylori lipid A induced comparable production of interleukin-6 (IL-6) by human peripheral blood mononuclear cells (PBMC) compared with P. gingivalis lipid A and compound 506. H. pylori lipid A also increased human natural killer cell activity, and strongly agglutinated rabbit erythrocytes. However, the lipid As of H. pylori and P. gingivalis showed lower activities in inducing tumour necrosis factor alpha (TNF-alpha) production by human PBMC and IL-8 production by human gingival fibroblasts than that of compound 506. The structural feature of H. pylori lipid A may be associated with low endotoxic properties and potent immunobiological activities.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9364689     DOI: 10.1016/s0264-410x(97)00102-3

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  26 in total

1.  Free lipid A isolated from Porphyromonas gingivalis lipopolysaccharide is contaminated with phosphorylated dihydroceramide lipids: recovery in diseased dental samples.

Authors:  Frank C Nichols; Bekim Bajrami; Robert B Clark; William Housley; Xudong Yao
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

2.  Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor alpha-inducing activities in macrophages through Toll-like receptor 2.

Authors:  Tetsuya Matsuguchi; Akimitsu Takagi; Takeshi Matsuzaki; Masato Nagaoka; Kimika Ishikawa; Teruo Yokokura; Yasunobu Yoshikai
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

3.  Type I Helicobacter pylori lipopolysaccharide stimulates toll-like receptor 4 and activates mitogen oxidase 1 in gastric pit cells.

Authors:  T Kawahara; S Teshima; A Oka; T Sugiyama; K Kishi; K Rokutan
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

4.  Biological characterization of lipopolysaccharide from Treponema pectinovorum.

Authors:  Lakshmyya Kesavalu; Clinton W Falk; Kenneth J Davis; Michelle J Steffen; Xiaoping Xu; Stanley C Holt; Jeffrey L Ebersole
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

5.  A novel 3-deoxy-D-manno-octulosonic acid (Kdo) hydrolase that removes the outer Kdo sugar of Helicobacter pylori lipopolysaccharide.

Authors:  Christopher Stead; An Tran; Donald Ferguson; Sara McGrath; Robert Cotter; Stephen Trent
Journal:  J Bacteriol       Date:  2005-05       Impact factor: 3.490

6.  Nod1 Imprints Inflammatory and Carcinogenic Responses toward the Gastric Pathogen Helicobacter pylori.

Authors:  Giovanni Suarez; Judith Romero-Gallo; Maria B Piazuelo; Johanna C Sierra; Alberto G Delgado; M Kay Washington; Shailja C Shah; Keith T Wilson; Richard M Peek
Journal:  Cancer Res       Date:  2019-01-29       Impact factor: 12.701

7.  Periplasmic cleavage and modification of the 1-phosphate group of Helicobacter pylori lipid A.

Authors:  An X Tran; Mark J Karbarz; Xiaoyuan Wang; Christian R H Raetz; Sara C McGrath; Robert J Cotter; M Stephen Trent
Journal:  J Biol Chem       Date:  2004-10-15       Impact factor: 5.157

8.  Microwave-assisted sample preparation for rapid and sensitive analysis of H. pylori lipid A applicable to a single colony.

Authors:  Ping Zhou; Vandana Chandan; Xin Liu; Kenneth Chan; Eleonora Altman; Jianjun Li
Journal:  J Lipid Res       Date:  2009-04-28       Impact factor: 5.922

9.  Helicobacter pylori lipopolysaccharide: biological activities in vitro and in vivo, pathological correlation to human chronic gastritis and peptic ulcer.

Authors:  Yi-Hui Luo; Jie Yan; Ya-Fei Mao
Journal:  World J Gastroenterol       Date:  2004-07-15       Impact factor: 5.742

10.  P. gingivalis and E. coli lipopolysaccharides exhibit different systemic but similar local induction of inflammatory markers.

Authors:  Rongkun Liu; Tesfahun Desta; Markos Raptis; Richard P Darveau; Dana T Graves
Journal:  J Periodontol       Date:  2008-07       Impact factor: 6.993

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.